Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Actimmune

About the author: 

Researchers have abandoned trials on the drug Actimmune as a treatment

Researchers have abandoned trials on the drug Actimmune as a treatmentfor idiopathic pulmonary fibrosis (IPF) after patients died while taking partin the study.

IPF is a chronic lung disease, and sufferers often die from severe short-ness of breath. So far, no drug has been developed to treat the condition, and the manufacturers of Actimmune believed that this drug could be the answer. It's a synthetic version of interferon gamma-1b, designed to reduce infections in patients with chronic granulomatous disease, a rare, congenital disorder of the white blood cells.

But when researchers tested Actim-mune on patients with IPF, they found that 14.5 per cent of patients died compared with 12.7 per cent with a placebo (www.fda.gov/cder/drug/InfoSheets/ HCP/interferon_gamma_1bHCP.htm).


Keeping your knees fit for life

Female hair loss

You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved